Cargando…

Oral Supplementation with Cholecalciferol 800 IU Ameliorates Albuminuria in Chinese Type 2 Diabetic Patients with Nephropathy

BACKGROUND: Low vitamin D levels can be associated with albuminuria, and vitamin D analogs are effective anti-proteinuric agents. The aim of this study was to investigate differences in vitamin D levels between those with micro- and those with macroalbuminuria, and to determine whether low dose chol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Yan, Yu, Haoyong, Lu, Junxi, Guo, Kaifeng, Zhang, Lei, Bao, Yuqian, Chen, Haibing, Jia, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510062/ https://www.ncbi.nlm.nih.gov/pubmed/23209764 http://dx.doi.org/10.1371/journal.pone.0050510

Ejemplares similares

Increased urinary Smad3 is significantly correlated with glomerular hyperfiltration and a reduced glomerular filtration rate and is a new urinary biomarker for diabetic nephropathy
por: Guo, Kaifeng, et al.
Publicado: (2015)

Protective Role of PGC-1α in Diabetic Nephropathy Is Associated with the Inhibition of ROS through Mitochondrial Dynamic Remodeling
por: Guo, Kaifeng, et al.
Publicado: (2015)

A Microalbuminuria Threshold to Predict the Risk for the Development of Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
por: Chen, Haibing, et al.
Publicado: (2012)

Nonalcoholic Fatty Liver Disease is Associated with Increased Carotid Intima-Media Thickness in Type 1 Diabetic Patients
por: Zhang, Lei, et al.
Publicado: (2016)

Per oral substitution with 300000 IU vitamin D (Cholecalciferol) reduces bone turnover markers in HIV-infected patients
por: Piso, Rein Jan, et al.
Publicado: (2013)

Monthly or Weekly Supplementation with Cholecalciferol 20,000 IU in People Living with HIV: Results from a Nested Cohort Study
por: Noe, Sebastian, et al.
Publicado: (2018)

Factors Associated with Increased Alpha-Tocopherol Content in Milk in Response to Maternal Supplementation with 800 IU of Vitamin E
por: de Sousa Rebouças, Amanda, et al.
Publicado: (2019)

Three monthly doses of 150,000 IU of oral cholecalciferol correct vitamin D deficiency in adolescents: A pragmatic study
por: Patseadou, Magdalini, et al.
Publicado: (2021)

Assessment of Vitamin D Metabolism in Patients with Cushing’s Disease in Response to 150,000 IU Cholecalciferol Treatment
por: Povaliaeva, Alexandra, et al.
Publicado: (2021)

Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
por: Li, Xu, et al.
Publicado: (2017)

A non-laboratory-based risk score for predicting diabetic kidney disease in Chinese patients with type 2 diabetes
por: Wu, Mian, et al.
Publicado: (2017)

Efficacy and safety of early supplementation with 800 IU of vitamin D in very preterm infants followed by underlying levels of vitamin D at birth
por: Cho, Sang Yeun, et al.
Publicado: (2017)

Vitamin D(3) Supplementation: Comparison of 1000 IU and 2000 IU Dose in Healthy Individuals
por: Dědečková, Eva, et al.
Publicado: (2023)

Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients
por: Yu, Haoyong, et al.
Publicado: (2012)

Efficacy of daily 800 IU vitamin D supplementation in reaching vitamin D sufficiency in nursing home residents: cross-sectional patient file study
por: Veleva, Bistra I, et al.
Publicado: (2014)

Cannabinoid Receptor 1 Blockade Ameliorates Albuminuria in Experimental Diabetic Nephropathy
por: Barutta, Federica, et al.
Publicado: (2010)

Recovery after unilateral knee replacement due to severe osteoarthritis and progression in the contralateral knee: a randomised clinical trial comparing daily 2000 IU versus 800 IU vitamin D
por: Bischoff-Ferrari, Heike A, et al.
Publicado: (2018)

Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy
por: Stangenberg, Stefanie, et al.
Publicado: (2018)

No effect of monthly supplementation with 12000 IU, 24000 IU or 48000 IU vitamin D3 for one year on muscle function: The vitamin D in older people study
por: Ranathunga, R.M.T.K., et al.
Publicado: (2019)

Oral Postdialysis Cholecalciferol Supplementation in Patients on Maintenance Hemodialysis: A Dose-Response Approach
por: Descombes, Eric, et al.
Publicado: (2014)

Vitamin D supplementation in older people (VDOP): Study protocol for a randomised controlled intervention trial with monthly oral dosing with 12,000 IU, 24,000 IU or 48,000 IU of vitamin D(3)
por: Schoenmakers, Inez, et al.
Publicado: (2013)

The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
por: Smelt, Hendrika J.M., et al.
Publicado: (2019)

Cholecalciferol supplementation and angiogenic markers in chronic kidney disease
por: Kaur, Jaskiran, et al.
Publicado: (2022)

A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial
por: Cannata-Andía, Jorge B., et al.
Publicado: (2022)

300 IU vs. 200 IU of OnabotulinumtoxinA for detrusor overactivity
por: Persu, Cristian
Publicado: (2014)

Beneficial Effects of an 8-Week, Very Low Carbohydrate Diet Intervention on Obese Subjects
por: Gu, Yunjuan, et al.
Publicado: (2013)

Pharmacokinetic Evaluation of a Single Intramuscular High Dose versus an Oral Long-Term Supplementation of Cholecalciferol
por: Wylon, Katharina, et al.
Publicado: (2017)

A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis
por: Bansal, Beena, et al.
Publicado: (2014)

The chloride/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals
por: Wang, Qianqian, et al.
Publicado: (2017)

Cardiac Murmurs Iu Chorea
Publicado: (1871)

Hyperuricemia and overexcretion of uric acid increase the risk of simple renal cysts in type 2 diabetes
por: Han, Ying, et al.
Publicado: (2017)

Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy
por: Wong, May YW, et al.
Publicado: (2020)

Vitamin D Deficiency in Mexican Pregnant Women: Is Supplementation with ≤400 IU/day Enough?
por: Perichart-Perera, Otilia, et al.
Publicado: (2020)

Diabetic nephropathy in mice is aggravated by the absence of podocyte IRE1 and is correlated with reduced kidney ADH1 expression
por: Xie, Liping, et al.
Publicado: (2021)

Baseline of visceral fat area and decreased body weight correlate with improved pulmonary function after Roux-en-Y Gastric Bypass in Chinese obese patients with BMI 28–35 kg/m(2) and Type 2 diabetes: a 6-month follow-up
por: Tu, Yinfang, et al.
Publicado: (2015)

Efficacy and Safety of 90,000 IU versus 300,000 IU Single Dose Oral Vitamin D in Nutritional Rickets: A Randomized Controlled Trial
por: Mittal, Medha, et al.
Publicado: (2018)

IU professor contributes to particle accelerator
Publicado: (2008)

Response to Antenatal Cholecalciferol Supplementation Is Associated With Common Vitamin D–Related Genetic Variants
por: Moon, Rebecca J., et al.
Publicado: (2017)

Effects on Serum Inflammatory Cytokines of Cholecalciferol Supplementation in Healthy Subjects with Vitamin D Deficiency
por: Fassio, Angelo, et al.
Publicado: (2022)

Determination of albuminuria in the urine of diabetics for prevention and control of diabetic nephropathy
por: Schroeder, Andreas, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_7ukcivh746fbhgrhrrn8ifdan5